AU2867092A - Mammalian gap-43 compositions and methods of use - Google Patents

Mammalian gap-43 compositions and methods of use

Info

Publication number
AU2867092A
AU2867092A AU28670/92A AU2867092A AU2867092A AU 2867092 A AU2867092 A AU 2867092A AU 28670/92 A AU28670/92 A AU 28670/92A AU 2867092 A AU2867092 A AU 2867092A AU 2867092 A AU2867092 A AU 2867092A
Authority
AU
Australia
Prior art keywords
compositions
methods
mammalian gap
mammalian
gap
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28670/92A
Inventor
Mark C. Fishman
Annette Beck Stickinger
Stephen M. Strittmatter
Yoshiaki Sudo
Dario Valenzuela
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of AU2867092A publication Critical patent/AU2867092A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU28670/92A 1991-10-11 1992-10-09 Mammalian gap-43 compositions and methods of use Abandoned AU2867092A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77409491A 1991-10-11 1991-10-11
US774094 1991-10-11

Publications (1)

Publication Number Publication Date
AU2867092A true AU2867092A (en) 1993-05-03

Family

ID=25100228

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28670/92A Abandoned AU2867092A (en) 1991-10-11 1992-10-09 Mammalian gap-43 compositions and methods of use

Country Status (2)

Country Link
AU (1) AU2867092A (en)
WO (1) WO1993006851A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994004562A1 (en) * 1992-08-13 1994-03-03 The General Hospital Corporation Mammalian gap-43 compositions and methods of use
AU1304895A (en) * 1993-12-07 1995-06-27 General Hospital Corporation, The Peptides to overcome inhibition of nerve growth

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0407543A4 (en) * 1988-12-22 1992-10-14 Fishman, Mark C. Mammalian gap-43 compositions and methods of use

Also Published As

Publication number Publication date
WO1993006851A1 (en) 1993-04-15

Similar Documents

Publication Publication Date Title
AU3076189A (en) Novel compositions and methods of use thereof
AU1913792A (en) Novel derivatives of thiopyranopyrrole and preparation thereof
AU626396B2 (en) Composition and use
ZA949668B (en) Optionally crosslinkable coatings compositions and methods of use
AU7294194A (en) Substituted heterocyclylisoquinolinium salts and compositions and method of use thereof
AU8154294A (en) Methods of inhibiting atrophy of the skin and vagina
AU6959694A (en) Antineoplastic compositions and methods of use
AU2065992A (en) Herbicidal compositions and methods of preparing and using the same
AU2114792A (en) Win 49596-finasteride method of use and compositions
AU1753892A (en) Mammalian gap-43 compositions and methods of use
AU8653091A (en) Crystallizing enamel composition and method of using the same
AU7400091A (en) Inhibitors of the advanced glycosylation of proteins and methods of use therefor
HU9600241D0 (en) Mutable composition and methods of use thereof
EP0673385A4 (en) Mammalian gap-43 compositions and methods of use.
AU3220993A (en) Crystallizing enamel composition and method of making and using the same
AU2490492A (en) Process for the preparation of beta-phenylisoserine derivatives and use thereof
AU651992B2 (en) Polyethylene terephthalate compositions and methods of using thereof
AU8427091A (en) Gamma-carboxylase and methods of use
AU8192691A (en) Method of treatment and compositions therefore
AU1714792A (en) Glass composition and use
AU4468093A (en) Composition and methods for the generation of bone
AU4243389A (en) Antimicrobial composition and method of use
GB2294637B (en) Therapeutic compositions and methods of use
AU6651794A (en) Automatisation of electro-oculographic examination
AU1106392A (en) Composition and use